With 30% of COPD cases misdiagnosed, experts call for improved diagnostic strategies, better disease classification, and ...

Emerging evidence shows glucose-lowering medications may have the potential to improve chronic obstructive pulmonary disease ...

Dupilumab added to standard COPD triple therapy reduces the annual rate of moderate exacerbations but not severe exacerbations.

Many people with COPD have other conditions like diabetes or high cholesterol, too. Managing several conditions can be ...

China: A recent multicenter randomized controlled trial has highlighted the potential benefits of acupuncture as a ...

Encouraging positive coping styles may improve family resilience and reduce the burden among COPD caregivers, according to ...

The worldwide increase in both COPD and diabetes cases underscores the importance of these findings. With projections indicating significant growth in affected populations, identifying treatments ...

Nov. 20, 2024 — A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave the way for new treatment ... Zinc Deficiency ...

Young COPD, referring to cases of COPD that occur in people aged 20–50 years, is often overlooked in research and clinical ...

The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

Atrial functional mitral regurgitation (AFMR) is a common type of MR linked to high rates of heart failure, highlighting the ...

Does gabapentinoid use increase the risk of severe exacerbation in patients with chronic obstructive pulmonary disease (COPD) ...